PharVision Advisers »

Pentair cs shares owned by PharVision Advisers

Quarter-by-quarter ownership of Pentair cs (PNR) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Pentair cs

Tip: Access up to 7 years of quarterly data

All positions including Pentair cs held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pentair cs by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $268k 2.7k 100.64

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Pentair cs

Vanguard Group
BlackRock
State Street Corporation
FMR
Geode Capital Management
Pictet Asset Management Holding SA
Amundi
Nordea Investment Management Ab
Invesco
Impax Asset Management Group
Ubs Global Asset Management Americas
Ameriprise Financial
Massachusetts Financial Services
Dimensional Fund Advisors
Northern Trust

View all funds holding Pentair cs